TEM – Tempus AI Inc
TEM — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
25.4
Margin Of Safety %
Put/Call OI Ratio
0.66
EPS Next Q Diff
0.26
EPS Last/This Y
0.97
EPS This/Next Y
0.3
Price
46.93
Target Price
66.53
Analyst Recom
2
Performance Q
-15.98
Upside
-228.2%
Beta
3.87
Ticker: TEM
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-04-13 | TEM | 46 | 0.65 | 0.24 | 282689 |
| 2026-04-14 | TEM | 49.55 | 0.63 | 0.32 | 290479 |
| 2026-04-15 | TEM | 56.46 | 0.61 | 0.19 | 299816 |
| 2026-04-16 | TEM | 54.53 | 0.57 | 0.48 | 323244 |
| 2026-04-17 | TEM | 55.31 | 0.58 | 0.32 | 330187 |
| 2026-04-20 | TEM | 56.78 | 0.65 | 0.44 | 264420 |
| 2026-04-21 | TEM | 55.7 | 0.65 | 0.65 | 274455 |
| 2026-04-22 | TEM | 55.73 | 0.65 | 0.39 | 279485 |
| 2026-04-23 | TEM | 51.84 | 0.65 | 0.39 | 282854 |
| 2026-04-24 | TEM | 52.46 | 0.63 | 0.60 | 293076 |
| 2026-04-27 | TEM | 52.7 | 0.65 | 0.60 | 273432 |
| 2026-04-28 | TEM | 50.97 | 0.65 | 0.37 | 281008 |
| 2026-04-29 | TEM | 50.02 | 0.65 | 0.41 | 287320 |
| 2026-04-30 | TEM | 55.4 | 0.64 | 0.35 | 295616 |
| 2026-05-01 | TEM | 54.96 | 0.65 | 0.44 | 301539 |
| 2026-05-04 | TEM | 55.91 | 0.66 | 0.39 | 288538 |
| 2026-05-05 | TEM | 53.18 | 0.66 | 0.46 | 297664 |
| 2026-05-06 | TEM | 53.55 | 0.65 | 0.50 | 312340 |
| 2026-05-07 | TEM | 49.57 | 0.67 | 0.69 | 321773 |
| 2026-05-08 | TEM | 49.86 | 0.67 | 0.64 | 331765 |
| 2026-05-11 | TEM | 48.46 | 0.66 | 0.51 | 311306 |
| 2026-05-12 | TEM | 46.95 | 0.66 | 0.66 | 321632 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-04-13 | TEM | 45.98 | 19.6 | -34.0 | -0.42 |
| 2026-04-14 | TEM | 49.53 | 19.2 | -35.6 | -0.42 |
| 2026-04-15 | TEM | 56.43 | 19.2 | -49.5 | -0.42 |
| 2026-04-16 | TEM | 54.44 | 18.3 | -10.4 | -0.43 |
| 2026-04-17 | TEM | 55.87 | 18.3 | -24.3 | -0.43 |
| 2026-04-20 | TEM | 56.77 | 16.2 | -21.9 | -0.45 |
| 2026-04-21 | TEM | 55.12 | 16.2 | -11.6 | -0.45 |
| 2026-04-22 | TEM | 55.54 | 16.2 | -19.9 | -0.45 |
| 2026-04-23 | TEM | 51.45 | 16.2 | -1.7 | -0.45 |
| 2026-04-24 | TEM | 52.12 | 16.2 | -21.2 | -0.45 |
| 2026-04-27 | TEM | 52.69 | 16.2 | -20.7 | -0.45 |
| 2026-04-28 | TEM | 51.12 | 16.2 | -11.6 | -0.45 |
| 2026-04-29 | TEM | 50.00 | 16.2 | -13.4 | -0.45 |
| 2026-04-30 | TEM | 55.46 | 16.2 | -42.7 | -0.45 |
| 2026-05-01 | TEM | 54.97 | 16.2 | -16.2 | -0.45 |
| 2026-05-04 | TEM | 55.80 | 16.2 | -21.5 | -0.45 |
| 2026-05-05 | TEM | 54.08 | 16.2 | -11.2 | -0.45 |
| 2026-05-06 | TEM | 53.52 | 16.2 | -15.9 | -0.45 |
| 2026-05-07 | TEM | 49.44 | 16.2 | 10.7 | -0.45 |
| 2026-05-08 | TEM | 49.86 | 24.8 | -15.3 | -0.44 |
| 2026-05-11 | TEM | 48.47 | 24.8 | -7.0 | -0.44 |
| 2026-05-12 | TEM | 46.93 | 24.8 | -6.2 | -0.44 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-04-13 | TEM | -2.00 | 9.45 | 26.48 |
| 2026-04-14 | TEM | -2.00 | 9.45 | 26.48 |
| 2026-04-15 | TEM | -2.00 | 9.45 | 26.48 |
| 2026-04-17 | TEM | -1.99 | 9.45 | 26.38 |
| 2026-04-20 | TEM | -1.99 | 9.34 | 26.38 |
| 2026-04-21 | TEM | -1.99 | 9.34 | 26.38 |
| 2026-04-22 | TEM | -1.99 | 9.34 | 26.29 |
| 2026-04-23 | TEM | -2.00 | 9.34 | 26.29 |
| 2026-04-24 | TEM | -2.00 | 9.34 | 26.29 |
| 2026-04-27 | TEM | -2.00 | 8.77 | 26.38 |
| 2026-04-28 | TEM | -2.00 | 8.77 | 26.38 |
| 2026-04-29 | TEM | -2.00 | 8.77 | 26.38 |
| 2026-04-30 | TEM | -1.78 | 8.77 | 26.38 |
| 2026-05-01 | TEM | -1.78 | 8.77 | 26.38 |
| 2026-05-04 | TEM | -1.78 | 7.76 | 26.38 |
| 2026-05-05 | TEM | -1.78 | 7.76 | 26.38 |
| 2026-05-06 | TEM | -1.78 | 7.76 | 26.38 |
| 2026-05-07 | TEM | -1.78 | 7.76 | 26.34 |
| 2026-05-08 | TEM | -1.78 | 7.76 | 26.34 |
| 2026-05-11 | TEM | -1.78 | 8.32 | 26.34 |
| 2026-05-12 | TEM | -1.78 | 8.32 | 25.40 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.37
Avg. EPS Est. Current Quarter
-0.17
Avg. EPS Est. Next Quarter
-0.11
Insider Transactions
-1.78
Institutional Transactions
8.32
Beta
3.87
Average Sales Estimate Current Quarter
380
Average Sales Estimate Next Quarter
412
Fair Value
Quality Score
40
Growth Score
52
Sentiment Score
4
Actual DrawDown %
55
Max Drawdown 5-Year %
Target Price
66.53
P/E
Forward P/E
PEG
P/S
6.18
P/B
20.21
P/Free Cash Flow
EPS
-1.72
Average EPS Est. Cur. Y
-0.44
EPS Next Y. (Est.)
-0.14
Target Price Estimates Raised
Target Price Estimates Lowered
1
Profit Margin
-22.2
Relative Volume
1.13
Return on Equity vs Sector %
-99.6
Return on Equity vs Industry %
-81.9
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.02
EBIT Estimation
-6.2
◆
TEM
Healthcare
$46.95
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
40.3
Range 1M
26.1%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
39.7%
EPS NY
75.3%
52W%
7.8%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+41.7% upside
Upside
+41.7%
Quality
40
Tempus AI, Inc.Sector: Healthcare
Industry: Health Information Services
Employees: 3800
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
TEM
Latest News
—
Caricamento notizie per TEM…
stock quote shares TEM – Tempus AI Inc Stock Price stock today
news today TEM – Tempus AI Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch TEM – Tempus AI Inc yahoo finance google finance
stock history TEM – Tempus AI Inc invest stock market
stock prices TEM premarket after hours
ticker TEM fair value insiders trading